SENS — Senseonics Holdings, Inc. Common Stock
NASDAQ · Healthcare · Medical Devices
$9.38
+$0.15 (+1.63%)
Senseonics Holdings, Inc. Common Stock (SENS) is a medical devices company listed on NASDAQ. It is led by Timothy T. Goodnow Ph.D., based in 20451 Seneca Meadows Parkway, Germantown, MD, United States, 20876-7005, with about 130 employees. Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Latest reported SENS revenue for 2025-09-30 was $8.1M. Net income was -$48.3M. Revenue was up 21.7% from 2025-06-30 to 2025-09-30. SENS currently screens at market cap $377.4M.
Use this SENS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SENS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SENS SEC filings page. Lician reads the product cache first so this HTML stays unique to Senseonics Holdings, Inc. Common Stock even when a live quote feed is slow.
About Senseonics Holdings, Inc. Common Stock
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
SENS Key Statistics
Market Cap
$377.43M
Volume
151,376
Previous Close
$9.38
Day Range
$9.31 – $9.74
P/B Ratio
10.99
EPS
-$0.12
Revenue
$22.47M
Net Income
-$78.62M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+0.4%
Profit Margin
-349.8%
Employees
130
SENS Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | $22.47M | $22.39M | $16.39M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 |
| Net Income | -$78.62M | -$60.39M | $142.12M |
| EPS (Diluted) | -$0.12 | -$0.11 | -$0.11 |
Total Assets
$100.44M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$74.60M
Operating Cash Flow
-$60.47M
Free Cash Flow
$0.00
Senseonics Holdings, Inc. Common Stock Company Information
- President, CEO & Director
- Timothy T. Goodnow Ph.D.
- Headquarters
- 20451 Seneca Meadows Parkway, Germantown, MD, United States, 20876-7005
- Website
- www.senseonics.com
- Phone
- 301 515 7260
- IPO / Founded
- 2016-03-17
- Sector
- Healthcare
- Industry
- Medical Devices